Pfizer has ended development of a B7-H4-directed antibody-drug conjugate (ADC), triggering a $1 billion impairment charge. | ...

Equities research analysts at Wedbush boosted their FY2024 EPS estimates for shares of Zentalis Pharmaceuticals in a research note issued to investors on Wednesday, January 29th. Wedbush analyst R.

Zentalis Pharmaceuticals (NASDAQ:ZNTL – Free Report) had its price target lowered by HC Wainwright from $20.00 to $10.00 in a research report released on Wednesday,Benzinga reports. The firm currently ...

uterine, and head-neck cancers. Patient stratify analysis revealed that NR0B2 expression is a favorite factor in liver cancer patients of Asian males with viral infection history. Correlation analysis ...

Use of long-acting, reversible contraceptives is associated with an increased risk of certain cancers, a study suggests.

The majority of women with uterine fibroids are asymptomatic, consequently get less clinical attention and fibroid tumors often remain undiagnosed. [23,24] Symptomatic women typically complain ...

An attorney representing the U.S. Department of Health & Human Services (HHS) said on Friday that the agency will ask Johnson & Johnson (NYSE:JNJ) to reimburse more than $1B for treating cancer ...

HHS and the Department of Veterans Affairs recently objected to J&J’s $10 billion proposed settlement of tens of thousands of ovarian cancer lawsuits, saying that resolving those cases in ...

Jan. 30, 2025 — A new study shows that artificial intelligence (AI) can help doctors make better decisions when treating cancer. However, it also highlights challenges in how doctors and AI work ...

UCLA has had a slew of former Bruins join Major League Baseball organizations. Several have made their way to the big leagues while multiple are still making their way up the chart. For the New ...